Autoimmune Disease Risk With GLP-1RA, DPP-4i, and SGLT2i Treatment in Patients With Diabetes. Mahajan A, Bates DW, Doria A, Foer D, LaChance AH, Sparks JA ACR Open Rheumatol. 2026 Jul; 8(7):e90046. PMID: 42415363. Abstract CommentRecommendBookmarkWatch
